PE16897A1 - Preparacion de triazoles por adicion organometalica a cetonas e intermedios del mismo - Google Patents
Preparacion de triazoles por adicion organometalica a cetonas e intermedios del mismoInfo
- Publication number
- PE16897A1 PE16897A1 PE1996000578A PE00057896A PE16897A1 PE 16897 A1 PE16897 A1 PE 16897A1 PE 1996000578 A PE1996000578 A PE 1996000578A PE 00057896 A PE00057896 A PE 00057896A PE 16897 A1 PE16897 A1 PE 16897A1
- Authority
- PE
- Peru
- Prior art keywords
- formula
- compound
- triazoles
- intermediates
- ketones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
SE REFIERE A UN PROCEDIMIENTO PARA PREPARAR COMPUESTOS DE FORMULA (I) O UNA DE SUS SALES DE ADICION DE ACIDOS O DE BASES, EN DONDE: R ES FENILO OPCIONALMENTE SUSTITUIDO POR 1 A 3 SUSTITUYENTES, SELECCIONADOS CADA UNO INDEPENDIENTEMENTE ENTRE HALO (PREFERIBLEMENTE FLUOR) Y TRIFLUOROMETILO; R1 ES ALQUILO DE C1-C6; Y Het ES PIRIMIDINILO OPCIONALMENTE SUSTITUIDO POR 1 A 3 SUSTITUYENTES, SELECCIONADOS CADA UNO INDEPENDIENTEMENTE ENTRE ALQUILO DE C1-C4, ALCOXI DE C1-C4, HALO, OXO, BENCILO Y BENCILOXI, PREFERIBLEMENTE Het ES 4-CLORO-5-FLUOROPIRIMIDIN-6-ILO, QUE COMPRENDE LA REACCION DE: 1) UN COMPUESTO DE FORMULA (II) EN LA QUE R ES COMO SE HA DEFINIDO PARA LA FORMULA (I); Y 2) UN COMPUESTO DE FORMULA (III), EN LA QUE R1 Y Het SON COMO SE HA DEFINIDO PARA LA FORMULA (I), Y, X ES CLORO, BROMO O YODO, PREFERIBLEMENTE BROMO, EN PRESENCIA DE ZINC, YODO Y/O UN ACIDO DE LEWIS PREFERIBLEMENTE CLORURO DE ZINC, Y UN DISOLVENTE ORGANICO APROTICO PREFERIBLEMENTE TETRAHIDROFURANO; OPCIONALMENTE SE CONVIERTE EL COMPUESTO DE FORMULA (I) EN UNA SAL DE ADICION DE ACIDOS O DE BASES DEL MISMO, PREFERIBLEMENTE EN UNA SAL CLORHIDRATO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9516121.2A GB9516121D0 (en) | 1995-08-05 | 1995-08-05 | Organometallic addition to ketones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE16897A1 true PE16897A1 (es) | 1997-05-21 |
Family
ID=10778850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1996000578A PE16897A1 (es) | 1995-08-05 | 1996-08-01 | Preparacion de triazoles por adicion organometalica a cetonas e intermedios del mismo |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US6586594B1 (es) |
| EP (1) | EP0871625B1 (es) |
| JP (3) | JP3211965B2 (es) |
| KR (1) | KR100269048B1 (es) |
| CN (1) | CN1076019C (es) |
| AR (1) | AR003472A1 (es) |
| AT (1) | ATE256679T1 (es) |
| AU (1) | AU703337B2 (es) |
| BR (1) | BR9609960A (es) |
| CA (1) | CA2228655C (es) |
| CZ (1) | CZ296975B6 (es) |
| DE (1) | DE69631160T2 (es) |
| DK (1) | DK0871625T3 (es) |
| EG (1) | EG21200A (es) |
| ES (1) | ES2210382T3 (es) |
| GB (1) | GB9516121D0 (es) |
| HK (1) | HK1014944A1 (es) |
| HU (1) | HU224339B1 (es) |
| IL (2) | IL122462A (es) |
| IN (1) | IN190817B (es) |
| MX (1) | MX9801025A (es) |
| MY (1) | MY123062A (es) |
| NO (1) | NO314938B1 (es) |
| NZ (1) | NZ315651A (es) |
| PE (1) | PE16897A1 (es) |
| PL (1) | PL187227B1 (es) |
| PT (1) | PT871625E (es) |
| RU (1) | RU2156760C2 (es) |
| TR (1) | TR199800170T1 (es) |
| TW (1) | TW442480B (es) |
| WO (1) | WO1997006160A1 (es) |
| ZA (1) | ZA966587B (es) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7193083B2 (en) * | 1996-07-26 | 2007-03-20 | Pfizer, Inc. | Preparation of triazoles by organometallic addition to ketones and intermediates therefor |
| TWI329105B (en) * | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
| MXPA05001096A (es) | 2002-07-29 | 2005-11-23 | Rigel Pharmaceuticals Inc | Metodos para tratamiento o prevencion de enfermedades autoinmunes con compuestos de 2,4-diamino-pirimidina. |
| US8178671B2 (en) * | 2003-07-30 | 2012-05-15 | Rigel Pharmaceuticals, Inc. | Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds |
| US20060058525A1 (en) * | 2004-09-01 | 2006-03-16 | Rajinder Singh | Synthesis of 2,4-pyrimidinediamine compounds |
| WO2006068770A1 (en) * | 2004-11-24 | 2006-06-29 | Rigel Pharmaceuticals, Inc. | Spiro-2, 4-pyrimidinediamine compounds and their uses |
| WO2006065726A2 (en) * | 2004-12-14 | 2006-06-22 | Dr. Reddy's Laboratories Ltd. | Process for preparing voriconazole |
| CA2604551A1 (en) * | 2005-05-03 | 2007-03-08 | Rigel Pharmaceuticals, Inc. | Jak kinase inhibitors and their uses |
| CA2640922A1 (en) * | 2006-02-01 | 2007-11-22 | Medichem, S.A. | Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof |
| AR061889A1 (es) | 2006-07-13 | 2008-10-01 | Medichem Sa | Proceso mejorado para la preparacion de voriconazol |
| CN1919846B (zh) * | 2006-09-14 | 2013-01-02 | 大道隆达（北京）医药科技发展有限公司 | 伏立康唑及其药用盐、中间体的一种新定向合成制备方法 |
| KR100889937B1 (ko) * | 2007-08-06 | 2009-03-20 | 한미약품 주식회사 | 보리코나졸의 제조방법 |
| GB2452049A (en) * | 2007-08-21 | 2009-02-25 | Alpharma Aps | Process for the preparation of voriconazole |
| WO2009084029A2 (en) * | 2007-12-03 | 2009-07-09 | Neuland Laboratories Ltd | Improved process for the preparation of (2r,3s)-2-(2,4- difluqrophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol |
| CN101575330B (zh) * | 2008-05-05 | 2012-10-31 | 丽珠医药集团股份有限公司 | 伏立康唑广谱抗真菌药物化合物、其组合物及用途 |
| US20110312977A1 (en) * | 2009-02-17 | 2011-12-22 | Glenmark Generics Limited | Process for the preparation of voriconazole |
| KR101109215B1 (ko) | 2009-06-17 | 2012-01-30 | 보령제약 주식회사 | 보리코나졸의 신규 중간체 및 이를 이용한 보리코나졸의 제조방법 |
| EP2470529B1 (en) | 2009-12-30 | 2014-11-19 | Medichem, S.A. | A 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivate with substantially undefined crystal shape for preparing said 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative |
| KR100971371B1 (ko) | 2010-02-04 | 2010-07-20 | 동국제약 주식회사 | 신규한 중간체를 이용한 보리코나졸의 제조방법 |
| WO2011110198A1 (en) | 2010-03-10 | 2011-09-15 | Synthron B.V. | A process for making voriconazole |
| CN101914091B (zh) * | 2010-07-25 | 2015-05-27 | 浙江华海药业股份有限公司 | 一种制备伏立康唑中间体的方法 |
| CN102344441B (zh) * | 2010-07-25 | 2015-05-06 | 浙江华海药业股份有限公司 | 一种制备伏立康唑中间体的工艺改进方法 |
| US20140350252A1 (en) | 2011-02-21 | 2014-11-27 | Nitin Maheshwari | Process for the preparation of voriconazole and intermediates thereof |
| EP2720723B1 (en) | 2011-06-15 | 2018-04-11 | Synthon BV | Stabilized voriconazole composition |
| CN102516233B (zh) * | 2011-12-09 | 2014-04-09 | 北京联本医药化学技术有限公司 | 生产伏立康唑的方法 |
| GR1007802B (el) * | 2012-01-31 | 2013-01-18 | Φαρματεν Αβεε, | Μεθοδος για την παρασκευη παραγωγου της βρωμοπυρινιδινης |
| CN104884450B (zh) | 2012-10-15 | 2017-03-29 | 辉瑞爱尔兰制药公司 | 制备伏立康唑及其类似物的方法 |
| KR101435741B1 (ko) | 2013-01-17 | 2014-08-29 | (주) 에프엔지리서치 | 신규한 보리코나졸 중간체 및 이를 이용한 보리코나졸의 제조 방법 |
| CN105503834B (zh) * | 2015-12-23 | 2021-03-05 | 浙江华海药业股份有限公司 | 一种伏立康唑中间体的合成方法 |
| CN106432198B (zh) | 2016-09-08 | 2022-10-21 | 浙江华海药业股份有限公司 | 一种制备伏立康唑拆分中间体的方法 |
| CN106632267B (zh) * | 2016-11-09 | 2019-02-22 | 中国科学院成都生物研究所 | 一种伏立康唑的合成方法 |
| CN108276310A (zh) * | 2017-01-06 | 2018-07-13 | 常州齐晖药业有限公司 | 一种伏立康唑拆分剂(r)-10-樟脑磺酸的回收方法 |
| CN108586433A (zh) * | 2017-07-21 | 2018-09-28 | 齐鲁工业大学 | 具有抗菌活性的伏立康唑盐酸盐 |
| CN109705102A (zh) * | 2019-02-19 | 2019-05-03 | 浙江华海立诚药业有限公司 | 伏立康唑及其中间体的制备方法 |
| CN110305113A (zh) * | 2019-07-05 | 2019-10-08 | 镇江市第四人民医院（镇江市妇幼保健院） | 一种伏立康唑杂质b的合成方法 |
| CN112442017A (zh) * | 2019-08-29 | 2021-03-05 | 珠海润都制药股份有限公司 | 一种采用微通道反应器制备伏立康唑消旋体的方法 |
| CN110724130A (zh) * | 2019-11-29 | 2020-01-24 | 怀化学院 | 伏立康唑及其中间体的合成方法 |
| CN111440152B (zh) * | 2020-05-18 | 2022-09-27 | 浙江诚意药业股份有限公司 | 一种伏立康唑的制备方法 |
| CN112079819B (zh) * | 2020-09-24 | 2022-06-17 | 南京易亨制药有限公司 | 一种改进的伏立康唑消旋体制备方法 |
| CN112645935A (zh) * | 2020-12-15 | 2021-04-13 | 植恩生物技术股份有限公司 | 伏立康唑关键中间体的制备方法 |
| CN115724829A (zh) * | 2022-12-23 | 2023-03-03 | 天津力生制药股份有限公司 | 一种分离真菌药物中间体杂质的液相色谱制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8819308D0 (en) * | 1988-08-13 | 1988-09-14 | Pfizer Ltd | Triazole antifungal agents |
| GB9002375D0 (en) * | 1990-02-02 | 1990-04-04 | Pfizer Ltd | Triazole antifungal agents |
| EP0665225B1 (en) * | 1994-02-01 | 1996-11-27 | Ube Industries, Ltd. | 4-Phenethylamino pyrimidine derivative, process for preparing the same and agricultural and horticultural chemical for controlling noxious organisms containing the same |
-
1995
- 1995-08-05 GB GBGB9516121.2A patent/GB9516121D0/en active Pending
-
1996
- 1996-07-13 TW TW085108523A patent/TW442480B/zh not_active IP Right Cessation
- 1996-07-26 CA CA002228655A patent/CA2228655C/en not_active Expired - Fee Related
- 1996-07-26 MX MX9801025A patent/MX9801025A/es not_active IP Right Cessation
- 1996-07-26 HU HU9802766A patent/HU224339B1/hu not_active IP Right Cessation
- 1996-07-26 JP JP50809797A patent/JP3211965B2/ja not_active Expired - Lifetime
- 1996-07-26 IL IL12246296A patent/IL122462A/en not_active IP Right Cessation
- 1996-07-26 US US09/011,346 patent/US6586594B1/en not_active Expired - Fee Related
- 1996-07-26 AT AT96927644T patent/ATE256679T1/de not_active IP Right Cessation
- 1996-07-26 IL IL13152196A patent/IL131521A/en not_active IP Right Cessation
- 1996-07-26 TR TR1998/00170T patent/TR199800170T1/xx unknown
- 1996-07-26 WO PCT/EP1996/003376 patent/WO1997006160A1/en active IP Right Grant
- 1996-07-26 EP EP96927644A patent/EP0871625B1/en not_active Expired - Lifetime
- 1996-07-26 BR BR9609960A patent/BR9609960A/pt not_active IP Right Cessation
- 1996-07-26 DE DE69631160T patent/DE69631160T2/de not_active Expired - Fee Related
- 1996-07-26 PT PT96927644T patent/PT871625E/pt unknown
- 1996-07-26 NZ NZ315651A patent/NZ315651A/xx unknown
- 1996-07-26 CZ CZ0032798A patent/CZ296975B6/cs not_active IP Right Cessation
- 1996-07-26 ES ES96927644T patent/ES2210382T3/es not_active Expired - Lifetime
- 1996-07-26 RU RU98103373/04A patent/RU2156760C2/ru not_active IP Right Cessation
- 1996-07-26 KR KR1019980700842A patent/KR100269048B1/ko not_active IP Right Cessation
- 1996-07-26 DK DK96927644T patent/DK0871625T3/da active
- 1996-07-26 PL PL96324922A patent/PL187227B1/pl not_active IP Right Cessation
- 1996-07-26 AU AU67403/96A patent/AU703337B2/en not_active Ceased
- 1996-07-26 CN CN96196097A patent/CN1076019C/zh not_active Expired - Fee Related
- 1996-07-31 IN IN1707DE1996 patent/IN190817B/en unknown
- 1996-08-01 PE PE1996000578A patent/PE16897A1/es not_active Application Discontinuation
- 1996-08-01 AR ARP960103831A patent/AR003472A1/es active IP Right Grant
- 1996-08-02 ZA ZA9606587A patent/ZA966587B/xx unknown
- 1996-08-03 MY MYPI96003196A patent/MY123062A/en unknown
- 1996-08-04 EG EG73196A patent/EG21200A/xx active
-
1998
- 1998-02-02 NO NO19980441A patent/NO314938B1/no not_active IP Right Cessation
-
1999
- 1999-01-07 HK HK99100036A patent/HK1014944A1/xx not_active IP Right Cessation
-
2000
- 2000-06-21 JP JP2000186089A patent/JP3224532B2/ja not_active Expired - Fee Related
-
2001
- 2001-04-27 JP JP2001131297A patent/JP2001354670A/ja active Pending
-
2003
- 2003-02-19 US US10/368,928 patent/US6946555B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE16897A1 (es) | Preparacion de triazoles por adicion organometalica a cetonas e intermedios del mismo | |
| KR100370990B1 (ko) | 헤테로고리화합물의술피닐화방법 | |
| PE39597A1 (es) | Nuevos plaguicidas | |
| GB932011A (en) | Improvements in or relating to dithiophosphonic acid ester derivatives suitable for use as insecticides | |
| HUP0004946A2 (hu) | Eljárás triazolintion-származékok előállítására és az új intermedierek | |
| GB785989A (en) | Improvements in or relating to plant treating materials | |
| AR032433A1 (es) | Proceso para la preparacion de un isomero de anillo de 5 miembros 3-sustituido y compuestos intermediarios utiles en el mismo | |
| US4774331A (en) | Process for ortho-cyanation of phenols or phenylamines | |
| JP6836791B2 (ja) | パーフルオロアルキル化化合物の製造方法 | |
| CS214680B2 (en) | Method of making the optically active derivatives of cyclopropancyrboxyle acid | |
| HU201319B (en) | Process for producing 3-isothiazolones | |
| GB1423644A (en) | 6-phenyl-s-triazolobenzotriazepines | |
| CO4750712A1 (es) | Adicion organometalica a cetonas | |
| HUP0003059A2 (hu) | Eljárás 2-alkiltiobenzoesav-származékok előállítására | |
| JPH06157418A (ja) | 還元的脱ハロゲン化法 | |
| US2776989A (en) | Process of preparing alpha-dichloromethyl benzhydrol esters | |
| GB1244910A (en) | Preparation of (cis-1,2-epoxypropyl)phosphonic acid, derivatives thereof and intermediates therefor | |
| US6365738B1 (en) | Preparation of heterocycles using 1,3-dihalopropenes | |
| US3666770A (en) | Process for preparing d-5,5-dimethyl-{66 {11 -thiazoline-4-carboxylic derivatives | |
| KR860007245A (ko) | 피페라지닐메틸-1,2,4-트리아졸일메틸-카빈올의 제조방법 | |
| US3793343A (en) | 5-amino-3,5-diphenyl-3-pyrrolin-2-ones | |
| ES2283781T3 (es) | Procedimiento para producir un compuesto de 1,2,3-triazol. | |
| GB928320A (en) | Alkylation of aromatic compounds | |
| DE60223274D1 (de) | Verfahren zur herstellung von 17beta-(substituierten)-3-oxo-delta 1,2-4-azasteroiden | |
| ECSP961843A (es) | Adicion organometalica a cetonas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |